Jenburkt Pharma
Company Overview - January 14, 2025
Jenburkt Pharma is a notable player in the Pharmaceuticals - Indian - Formulations industry, listed on the BSE (Code: 524731). As of the January 14, 2025, the company holds a market capitalization of INR 538.43 crores, placing it among the top-performing companies in its sector.
With a current stock price of INR 1220.00, Jenburkt Pharma has demonstrated a 82.52% return over the last year. Recent performance indicates fluctuations, with a 5.93% change in the past week and a 28.37% change over the last month. The company's all-time high stands at INR 1375.00, while its lowest-ever price was INR 13.45.
In terms of sales, Jenburkt Pharma reported a revenue of INR 148.26 crores, solidifying its position in the market. The average trading volume over the past month has been 4794 shares, with a more recent weekly average of 2747.
With the stock trading above its 50-day moving average of INR 1106.97, the company's technical indicators like MACD (44.42) signal positive trends.
Company Data
| Name | Jenburkt Pharma |
|---|---|
| BSE Code | 524731 |
| NSE Code | |
| Industry | Pharmaceuticals - Indian - Formulations |
| Current Price | 1220.00 |
| Market Capitalization | 538.43 |
| Sales | 148.26 |
| Return over 3months | 10.78 |
| Return over 6months | 46.87 |
| Volume 1month average | 4794 |
| Volume 1week average | 2747 |
| Volume | 867 |
| High price | 1375.00 |
| Low price | 643.20 |
| High price all time | 1375.00 |
| Low price all time | 13.45 |
| Return over 1day | -0.92 |
| Return over 1week | 5.93 |
| Return over 1month | 28.37 |
| Return over 1year | 82.52 |
| Return over 3years | 32.21 |
| Return over 5years | 24.78 |
| Volume 1year average | 3426 |
| DMA 50 | 1106.97 |
| DMA 200 | 951.28 |
| DMA 50 previous day | 1101.89 |
| DMA 200 previous day | 948.47 |
| MACD | 44.42 |
| MACD Signal | 39.85 |